SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-002565
Filing Date
2020-01-08
Accepted
2020-01-08 17:23:37
Documents
2
Period of Report
2020-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2171
2 POA DOCUMENT poa.txt EX-24.3_887913 3785
  Complete submission text file 0001209191-20-002565.txt   7399
Mailing Address C/O VAXGEN INC 1000 MARINA BLVD. #200 BRISBANE CA 94005
Business Address
PANEK JAMES P (Reporting) CIK: 0001217412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 20516465

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)